310 related articles for article (PubMed ID: 400938)
1. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
Richmond MH
Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
3. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
Richmond MH
Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactamases: a new twist to an old problem.
Nichols WW
Microbiol Sci; 1987 May; 4(5):147-8. PubMed ID: 3153189
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamases as the main resistance factor to penicillin-related antibiotics.
Frère JM; Joris B
Ann Biol Clin (Paris); 1988; 46(2):151-6. PubMed ID: 3260085
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
Nitzan Y; Deutsch EB; Pechatnikov I
Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
[TBL] [Abstract][Full Text] [Related]
8. Anaerobic bacteria and beta-lactam antibiotics.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
[TBL] [Abstract][Full Text] [Related]
9. Emergence and mechanisms of bacterial resistance in surgical infections.
Neu HC
Am J Surg; 1995 May; 169(5A Suppl):13S-20S. PubMed ID: 7755162
[TBL] [Abstract][Full Text] [Related]
10. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
11. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
12. An explicit model for bacterial resistance: application to beta-lactam antibiotics.
Waley SG
Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
Kotra LP; Mobashery S
Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
[TBL] [Abstract][Full Text] [Related]
14. The evolution of antibiotic production and public health problems.
Mansford KR; Slocombe B
Chemioterapia; 1987 Jun; 6(3):234-40. PubMed ID: 3496977
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Bujdáková H; Kallová J; Lausová A; Kettner M
Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
[TBL] [Abstract][Full Text] [Related]
16. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
Walsh TR
Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
Semenitz E
Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
[TBL] [Abstract][Full Text] [Related]
18. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
Sougakoff W; Jarlier V
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
[TBL] [Abstract][Full Text] [Related]
19. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
Zhao WH; Asano N; Hu ZQ; Shimamura T
J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
[TBL] [Abstract][Full Text] [Related]
20. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
Dudley M
Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
